A flurry of acquisitions, mergers and other cannabis sector deals followed President Donald Trump’s Dec. 18 executive order instructing marijuana’s status under federal law to be downgraded.
But while some observers agree that this historic step – and with it, the promise of other major reforms – appears to have been the determining factor pushing at least some of these deals across the finish line, cannabis M&A stands to be transformed when marijuana rescheduling is finalized, analysts contacted for this article told MJBizDaily.
ADVERTISEMENT
“The signed deals we’re seeing are deals that have been worked on for some time now, and the signing of the EO was the catalyst to close those deals,” said Avis Bulbulyan, CEO of California-based cannabis consultancy Siva.
“Over the
Read full article on Marijuana Business Daily
